Letter from the New Editor in Chief
págs. 165-166
Chidamide tablets: HDAC inhibition to treat lymphoma.
Y. Xu, P. Zhang, Yang Liu
págs. 167-175
Sofosbuvir/velpatasvir fixed-dose combination for the treatment of chronic hepatitis C virus infection.
Vandana Nehra, Stacey A. Rizza, Zelalem Temesgen
págs. 177-190
Promising cardiovascular and blood pressure effects of the SGLT2 inhibitors: a new class of antidiabetic drugs.
Steven G. Chrysant
págs. 191-202
Evidence Europe 2017. London, UK – February 22-23, 2017.
Alexandra Kibble
págs. 203-208
New product intros (daclatasvir hydrochloride/asunaprevir/beclabuvir [new combination]; sarilumab).
págs. 209-210
Dr. Eugene Garfield, 1925 - 2017
pág. 211
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: